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ABSTRACT 
SELECTIVE FORCES THAT SHAPE THE VLS ANTIGENIC VARIATION SYSTEM 
IN BORRELIA BURGDORFERI 
Wei Zhou 
Dustin Brisson 
Evolutionary success of microbial pathogens requires survival within hosts, despite the 
rapidly changing and lethal immune response. Pathogens such as the Lyme disease 
bacteria Borrelia burgdorferi have evolved antigenic variation systems that are necessary 
for survival within the adverse immune environment. Although antigenic variation 
systems are essential to both microbial pathogenesis and microbial evolution, it is largely 
unclear what selective forces have influenced the evolution of antigenic variation systems. 
In this thesis, we investigate evolution of the vls antigenic variation system in B. 
burgdorferi by asking two major questions: First, what traits relevant to the vls antigenic 
variation system have natural selection acted on? Second, how did the selective forces 
shape the genetic sequences of the vls antigenic variation systems? We characterize 
sources of natural selection using mathematical modeling, computational simulation and 
mutagenesis experiments. Our findings show that natural selection has promoted 
diversity among VlsE variants on both sequence and structure by organizing the variable 
sites in the vls unexpressed cassettes. We also show that the level of diversity among the 
VlsE variants may strongly influence the within-host dynamics of Bb, an important 
fitness component of B. burgdorferi. Finally, our results indicate that diversity among 
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VlsE variants might be constrained by purifying or stabilizing selections on translational 
efficiency and structural stability of the VlsE variants. 
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Chapter 1. Introduction 
1.1. Background: Rapidly changing host immune environment 
All reproducing organisms are faced with changing environments and have to cope with 
the potential decrease in fitness caused by environmental changes. Although 
environmental changes with minimal fitness impact may be simply tolerated, 
evolutionary success often requires changes in morphology, physiology or behavioral 
traits to maintain high fitness in the face of large environmental changes [1-3]. The 
ability to respond to environmental changes is especially important for the evolutionary 
success of plants and microbes because they have limited mobility and are less capable of 
physically escaping from changed environments [4]. A fundamental question in microbial 
evolution is how microbes manage to survive within rapidly changing environments.  
The host immune system is a particularly adverse and rapidly fluctuating environment for 
microbial parasites. The host’s immune response to an invading parasite consists of a 
variety of components that are spatially and temporally variable. One typical mechanism 
of the response is the antibody-mediated adaptive immune response. Clones of antibody-
producing B cells are selected from a pool of up to 109 clones to maximize affinity of 
antibodies to the invading parasite. Selected clones of B cells then secrete antibodies that 
bind to parasitic antigens with a high affinity. This process happens repeatedly to keep 
the antibody population highly reactive to newly expressed parasitic antigens.  Moreover, 
changes in B cell populations can happen very rapidly: in young rats, newly proliferated 
B cells can replace the peripheral B cell pool within days [5]. The high-affinity antibodies 
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bind to parasitic antigens, recruiting immune effector cells and immune effector 
molecules to efficiently remove the antibody-bound parasite cells. Therefore, antibody 
response creates a rapidly changing and adverse environment for microbial parasites.  
1.2. Background: Antigenic variation systems in microbial parasites 
The parasites need to persist within hosts despite the lethal antibody response so as to 
elevate within-host density of the parasites and to increase the probability of transmission 
to naïve hosts [6, 7], both of which are vital fitness components. The ability of microbial 
parasites to introduce antigenic diversity is essential to surviving the antibody response. 
The reasons are twofold: First, due to specificity of the antibody response, diversity 
among the parasitic antigens is needed to facilitate the evasion of antibody recognition 
and killing. It has been suggested that the probability that a subset of the parasite 
population can evade the antibody response is a function of the diversity of antigens 
within the host [8]. Second, the parasite population continues to lose standing variation 
due to a dynamic selection imposed by the antibody population. That is, only a subset of 
parasitic antigens can evade each antibody, and if new variation is not generated in time, 
that subset will also become extinct when the antibody population evolves to target the 
subset.  
As an adaptation to the immune environment, a lot of microbial parasites have evolved 
mechanisms to promote diversity at a rate higher than expected given the genome-wide 
mutation rate. These mechanisms include hypermutation at contingency loci, phase 
variation and antigenic variation [9, 10]. Contingency loci are regions of highly mutable 
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DNA which often encode proteins located at the interface between the microbe and the 
environment [7]. These loci usually mutate in a stochastic manner (ie. without sensing the 
environment) to rapidly and continuously generate genetic variations, and thus arguably 
facilitate adaptation to changing environments by increasing evolvability [11-13]. Phase 
variation describes a reversible and often random switch between gene expression 
profiles which can occur at a rate as fast as 1 switch per 10 replications [10]. Microbial 
parasites switch between different phases during different stages of pathogenesis due to 
significant environmental changes [14-16]. Although similar to normal gene regulation, 
phase variation is distinctive in that it involves some forms of heritability, either genetic 
or epigenetic, of the altered phenotype [10]. 
Antigenic variation refers to the alternation of a particular surface antigen through DNA 
rearrangement [10, 17]. In terms of molecular mechanisms, such rearrangement is 
commonly realized through homologous recombination between an expression locus and 
a library of unexpressed, silent paralogs. As an example, Borrelia burgdorferi (Bb), the 
causative agent of Lyme disease, takes advantage of a cassette-based mechanism to evade 
the host immune response against its surface antigen VlsE (Figure 1-1) [18, 19]. VlsE is a 
35kDa surface lipoprotein that is antigenically dominant when the bacteria infect 
vertebrate hosts. Each Bb genome has an array of 10-20 unexpressed cassettes that are 
paralogous to vlsE and are located within the linear plasmid lp28-1. DNA sequences of 
the vls cassettes are very similar to the cassette region of vlsE, but also have mutations 
that are concentrated in six variable regions. Random segments of the silent cassettes are 
continuously introduced into vlsE through homologous and nonreciprocal recombination, 
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altering the sequence and the structure of the VlsE antigen [18-20]. It has been shown 
that without the vls antigenic variation system, the infection duration and the ability of Bb 
to disseminate to different tissues of laboratory mice are dramatically reduced [21-24]. 
Microbial pathogens benefit from antigenic variation in several ways. First, antibodies 
that specifically target the original form of an antigen may have a decreased affinities to 
the protein variants [8, 9, 17, 25]. Second, antigenic variation increases polymorphism in 
the transmittable pool of pathogens, which increases the success rate in reinfection or 
transmission [8, 25]. Third, when a host primed by the original form of an antigen is met 
with a variant of the same antigen, it tends to activate a memory response against the 
original antigen instead of a primary response against the variant [25]. In this case, the 
memory response will likely be inefficient because it does not specifically target the 
antigenic variant. This phenomenon, known as the Hoskins effect, infers that 
polymorphism in a transmittable pool can not only permit reinfection, but might also 
render the host more susceptible after a primary infection [25]. Finally, variability of 
antigens may help counter the variability in immune systems among hosts with different 
genetic backgrounds [25]. 
In addition to its importance in microbial infection, antigenic variation systems are a 
suitable model to study microbial responses to rapidly fluctuating environments. For 
recombination-based antigenic variation systems such as the vls antigenic variation 
system, the genetic information for all possible antigenic variants is encoded in the 
sequences of the paralogs [9, 10, 26]. Therefore, the antigenic variants that a parasite can 
express can be explored by analyzing the sequences of the antigenic paralogs. For the vls 
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antigenic variation system in Bb, antigenic variants of vlsE continuously sample DNA 
segments from the unexpressed cassettes. Therefore, selective pressure on the antigenic 
variants imposed by the immune system is in turn reflected in the sequences of the 
unexpressed cassettes. Earlier work has shown evidence of strong diversifying selection 
in the unexpressed cassettes of the vls antigenic variation system: the dN/dS ratio among 
the unexpressed cassettes is exceptionally high, which indicates that the unexpressed 
cassettes are under strong selection for the probability of amino acid alterations within 
the expression site [27]. This is likely because diversity among the unexpressed cassettes 
need to be elevated to ensure that the newly generated VlsE variants are divergent enough 
from the parental VlsE targeted by the antibodies, so as to evade the recognition of the 
extant antibodies. 
Despite the strong diversifying selection, not all sites are variable even within the 
variable regions of vlsE. The existence of invariant sites suggests that either variation at 
the invariant sites has little effect on immune recognition, or purifying selection has 
limited the variability at these sites. Purifying selections may act on protein-coding genes, 
including antigens of parasites, because changes that disrupt the structure or function of 
the protein are detrimental. Although the full function of VlsE is yet unclear, it has been 
suggested that VlsE can protect cell surface proteins from immune responses because of 
its immunodominance [28], high level of expression within vertebrate hosts [29, 30] and 
co-localization with other cell surface proteins [21]. Excessive alteration in the sequence 
of the antigen can potentially undermine its efficiency in expression, correct folding, 
structural stability and resistance to proteases [31]. Therefore, antigenic variation systems, 
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including vls, should be selected to promote antigenic diversity, but only within 
constraints of the structural and functional integrity of the antigen [10]. 
 
Figure 1-1. vls antigenic variation system in Bb. (A) the vlsE expression site and an array 
of unexpressed vls cassettes are located on the linear plasmid lp28-1 in Bb. (B) the 
cassette region of vlsE and the vls unexpressed cassettes are composed of variable regions 
(VR) with a high concentration of mutations and invariable regions (IR) that are highly 
conserved among the cassettes. 
1.3. Scientific questions and dissertation structure 
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Despite the importance of antigenic variation systems in microbial pathogenesis and 
microbial evolution, it is largely unknown how natural selection, including diversifying 
selection and purifying selection, organize the genetic sequences of antigenic variation 
systems. For example, in the vls antigenic variation system, it is unclear what sources of 
selection have acted on the VlsE variants and how these selective forces have influenced 
the sequences of the vls unexpressed cassettes. This dissertation investigates potential 
sources of natural selection that have organized variable sites within the vls unexpressed 
cassettes.  
Chapter 2 presents a study of potential sources of natural selection affecting the 
nucleotide identities at, and positions of, the variable sites within the variable regions of 
the unexpressed vls cassettes. The study uses computational modeling and simulation to 
investigate how perturbations in the variable and invariant nucleotides within the variable 
regions of the unexpressed cassettes alter diversity and translational efficacy among the 
resulting VlsE variants. The results suggest that the nucleotide identities and positions of 
the variable sites are selected for higher sequence diversity among the VlsE variants 
within strong constraints on protein translational ability.  
Chapter 3 examines the influence of diversity among variants of VlsE on Bb dynamics 
within hosts. Dynamics models are used to describe temporal changes in VlsE variant 
types, antibody response, immune effector cells and Bb abundance within-host. 
Numerical simulation based on the models predicts that diversity among antigenic 
variants significantly influence Bb dynamics when Bb is strongly suppressed by the 
immune system.  
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Chapter 4 investigates sources of natural selection acting on structure-level properties of 
the VlsE antigen. We test the hypothesis that variable amino acid residues in the variable 
regions of VlsE are more likely targeted by antibodies than the invariable residues in the 
variable regions of VlsE. A correlation between variability and antigenic importance of 
amino acid residues within the variable regions of VlsE is supported by computational 
analysis, but not consistently supported by experimental analysis. We discuss possible 
mechanisms that may lead to the discrepancy.  
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Chapter 2. Selection for sequence diversity and 
translational efficacy among VlsE variants 
This chapter was adapted from: 
Zhou, W. and D. Brisson. 2014. Potentially conflicting selective forces that shape the vls 
antigenic variation system in Borrelia burgdorferi. Infect Genet Evol. 27:559-65. 
2.1. Introduction 
The persistence within vertebrate hosts in the face of the potentially lethal environmental 
conditions imposed by the immune system is a primary constituent of the evolutionary 
fitness of many microbial pathogens [6, 8, 32, 33]. These strong selective pressure 
imposed by the immune response has resulted in antigenic variation mechanisms evolved 
to cope with this rapidly changing environment [6-8, 25, 33].  
Antigenic variation systems alter surface antigens of pathogens, giving rise to 
subpopulations of pathogens with distinct antigenic variants that are not recognized by 
antibodies targeting previously detected antigens [10]. Antigenic variation systems that 
more efficiently alter surface antigens of the pathogen are likely to be selectively 
advantageous as they promote greater residence time within hosts and transmission to 
naïve hosts, both of which are primary components of pathogen fitness. 
One common molecular mechanism of antigenic variation involves recombining gene 
fragments from unexpressed, paralogous cassettes into an expression site, thereby altering 
the sequence of the expressed antigen. In these types of recombination-based antigenic 
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variation systems, which are common in several bacterial genera [18, 34, 35], the ability 
to alter the sequence of the expressed antigen is correlated with the amount of diversity 
among the unexpressed cassettes. Thus, natural selection should favor ever greater 
diversity among unexpressed cassettes to promote ever greater divergence among 
expressed antigens [27, 36]. However, the extent of the divergence among cassettes can 
be constrained by other features of the system [37] . Here, we use the well-characterized 
vls antigenic variation system in the Lyme disease bacterium, Borrelia burgdorferi (Bb), 
as a model system to investigate the interactions between selection favoring greater 
antigenic divergence and other potential constraints on antigenic variation systems.  
Bb requires continuous alteration of the highly-expressed VlsE antigen for long-term 
survival within hosts [18, 22-24, 38, 39]. A fragment of an unexpressed vls cassette can 
be introduced into the vlsE expression site through nonreciprocal recombination, thus 
changing, adding, or removing nucleotides in sequence of the expression site resulting in 
the expression of a divergent VlsE antigen. However, altering the sequence in the 
expression site could potentially reduce the ability to translate a functional protein– by 
introducing stop codons or frameshift mutations – or reduce translational efficiency and 
accuracy– by introducing non-preferred codons [20, 40]. Little is currently known about 
how selection on both antigenic divergence and translational ability or efficiency 
constrains the nucleotide identities at the variable sites, positions of the variable sites and 
positions of the insertion/deletion mutations. 
Here we evaluated the effects of the identity of nucleotides at variable sites, positions of 
the variable sites, and position of insertion/deletion mutations in the unexpressed 
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cassettes on the divergence among VlsE variants as well as their translational ability and 
translational efficiency. We ask if the organization of variable sites and insertion/deletion 
mutations in the unexpressed cassettes of multiple natural strains promotes sequence 
divergence, translational ability, and translational efficiency in the VlsE variants. We 
used in silico simulation models to test if perturbing the observed variable sites leads to a 
decrease in sequence divergence, translational ability and translational efficiency.  
2.2. Materials and Methods 
2.2.1. Sequence analysis of vlsE and the unexpressed cassettes 
The sequences of the unexpressed cassettes from six strains of Bb and one B. afzelii strain 
were used to investigate how diversifying selection and translational selection constrain 
identities and locations of variable sites among the unexpressed cassettes (Table 2-1). 
Each of the unexpressed cassettes within each strain was aligned using ClustalW [41] 
with default parameters. The unexpressed vls cassettes from all strains have six or seven 
variable regions in which variable sites are concentrated as described by Zhang et al [18]. 
Unexpressed cassettes that did not include all variable regions were not analyzed. 
12 
 
  
Strains Number of 
polymorphic sites 
Number of  
variable regions 
Reference 
B31 191 6 Zhang et al. [20] Schutzer, 
Fraser-Liggett [42]  
JD1 166 6 Schutzer, Fraser-Liggett [42] 
WI9123 115 6 Schutzer, Fraser-Liggett [42] 
29805 140 6 Schutzer, Fraser-Liggett [42] 
Bol26 234 6 Schutzer, Fraser-Liggett [42] 
Zs7 90 6 Schutzer, Fraser-Liggett [42] 
B. afzelii 223 7 Wang, Botkin [43] 
 
Table 2-1. Unexpressed cassettes in six strains of Bb and in B. afzelii 
 
2.2.2. In silico perturbation of unexpressed cassettes 
For each set of natural cassettes, three perturbation models were generated using the three 
algorithms (δNuc, δPos, and δInDel) described below and in Figure 2-1. The perturbation 
models have altered either a) nucleotide identity at each variable site (δNuc), b) the 
locations of the variable sites within the variable regions (δPos), or c) the locations of 
insertion/deletion mutations within the variable regions (δInDel). All perturbation models 
were run independently on each strain to generate 50 iterations of perturbed cassettes.  
The maximum-likelihood nucleotide substitution rates at the vls unexpressed cassettes in 
each strain was estimated under the General Time Reversible (GTR) nucleotide 
substitution model [44], which allows for different nucleotide frequencies and nucleotide 
substitution rates, using PhyML [45]. The maximum-likelihood substitution model was 
used to estimate the stationary frequencies of nucleotides in the unexpressed cassettes, 
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which was subsequently compared to the observed frequencies of nucleotides in the 
unexpressed cassettes.  If the two frequency distributions were not significantly different, 
we concluded that nucleotide substitution has reached equilibrium among the 
unexpressed cassettes. To show that the model predictions are robust to the choice of 
nucleotide substitution model, perturbed cassettes that have altered nucleotide identities 
at the variable sites (δNuc) or locations of the variable sites (δPos) were generated by 
sampling nucleotides from both the maximum-likelihood stationary distribution and a 
uniform distribution assuming equal rate of substitution between any pair of nucleotides.  
2.2.2.1. δNuc algorithm 
The δNuc algorithm converts the nucleotides observed at every variable site in the 
cassettes of each natural strain to an alternative nucleotide (Figure 2-1A). That is, all 
nucleotides of identity X are converted to identity Y (for example, all adenines at a given 
variable site are converted to cytosines). The identity of the nucleotide to replace the 
original nucleotide is sampled either at random or from the maximum-likelihood 
stationary nucleotide frequency at the locus for each polymorphic site in each iteration of 
the model. Nucleotide conversion is bijective – all nucleotides at a variable site of 
nucleotide identity X will be converted to identity Y, and nucleotides of identity Y will 
only be used to replace identity X at that variable site. The δNuc algorithm only replaces 
nucleotides that differ from that observed in the vlsE sequence such that the total number 
of nucleotides that differ from the parental vlsE is not altered.  
2.2.2.2. δPos algorithm  
The δPos algorithm relocates the position of all variable sites of a given strain except 
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those sites that contain insertion/deletion mutations, to a random position within the 
variable regions of the unexpressed cassettes (Figure 2-1B). The nucleotide identities at 
the relocated variable sites are altered following the δNuc algorithm (2.2.2.1). 
2.2.2.3. δInDel algorithm 
The δInDel algorithm relocates the position of all variable sites, including those that 
contain insertion/deletion mutations, to random positions within the variable regions of 
the unexpressed cassettes (Figure 2-1C). The nucleotide identities at the relocated sites 
are sampled at random as in the δNuc algorithm (2.2.2.1), with the addition of gap as a 
fifth possible type of ‘nucleotide’ that can be replaced and can be used for replacement. 
  
15 
 
 
Figure 2-1. Examples of algorithms perturbing the organizations of polymorphic sites. (A) 
δNuc converts the polymorphic nucleotides to alternative nucleotides. (B) δPos relocates 
polymorphic sites within the variable regions. The relocated polymorphic sites are then 
perturbed as in δNuc. (C) δInDel relocates the polymorphic sites including those with 
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insertion/deletion mutations within the variable regions. The new polymorphic sites are 
then perturbed as in δNuc, with the addition of gap as a fifth type of ‘nucleotide’. 
 
2.2.3. In silico simulation of recombination events 
Five hundred VlsE variants were generated from the natural unexpressed cassettes from 
each of the seven Borrelia genotypes analyzed, as well as from each of the in silico-
perturbed sets of unexpressed cassettes. Each VlsE variant was generated by simulating 
one recombination event between the unexpressed cassettes and the natural vlsE sequence. 
For each recombination event, a segment was selected at random from the set of 
unexpressed cassettes and used to replace the homologous segment in the vlsE sequence 
observed in the natural strain. The length of the selected segment was chosen at random 
from an even distribution between 2 to 200bp. The range and distribution of segment 
lengths was derived from lengths of recombining fragments observed in Bb strains 
infecting laboratory mice [20].  
2.2.4. Sequence divergence, translational ability, and translational efficiency of VlsE 
variants 
We evaluated sequence divergence, translational ability, and translational efficiency of 
each of the VlsE variants generated from the in silico recombination events from each of 
the natural and perturbed unexpressed cassette.  
2.2.4.1. Estimation of sequence divergence 
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Amino acid sequence divergence is correlated with antigenic divergence [25, 46, 47]. 
Amino acid sequence divergence between the in silico-generated VlsE variant and the 
natural VlsE sequence was estimated by calculating the ratio of non-identical amino acids 
in the alignment of the two sequences (amino acid weight matrix=GONNET, gap 
opening penalty=10, gap extension penalty=0.1).  
2.2.4.2. Estimation of translational ability 
Translational ability was defined as sequences that do not encode premature stop codons 
or frameshifts that are not corrected prior to the terminal stop codon. vlsE sequences that 
contained either premature stop codons or an unreverted frameshift had zero translational 
ability while those that could produce a complete protein had translational ability equal to 
one. 
2.2.4.3. Estimation of translational efficiency 
Although translational efficiency is determined by multiple factors, variations in 
elongation rate among VlsE variants may be especially important in the translational 
efficiency of this highly expressed protein because the recombination mechanism does 
not alter the 5’ or 3’ sequences of the expression site and thus does not alter initiation and 
termination rates [18]. Codons with more abundant tRNAs are likely to be translated with 
a greater elongation rate and with greater accuracy [40]. Thus, optimality of codon usage 
with respect to tRNA abundance was used as a proxy for translational efficiency. Codon 
optimality was estimated using two statistics, average tRNA copy number and tRNA 
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adaptation index, both of which have been shown to correlate with tRNA abundance [48-
51] and codon decoding rate in many prokaryotes [52].  
tRNA copy number, E(T), was estimated as the number of copies of tRNA genes that pair 
to a codon, averaged over all codons in the vlsE sequence:  
E(T) = 1
𝑛𝑛
�𝑇𝑇𝑖𝑖
𝑛𝑛
𝑖𝑖=1
 
where n is the total number of codons in a vlsE variant, Ti is the number of copies of 
tRNA genes in the genome that pair with the ith codon [53].  
tRNA adaptation index, tAI, was calculated according to dos Reis et al [52]. First, the 
absolute adaptiveness value Wi for the ith codon was calculated: 
Wi = �(1 − 𝑆𝑆𝑖𝑖𝑖𝑖)𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑖𝑖𝑖𝑖𝐼𝐼𝑖𝑖
𝑖𝑖=1
 
where Ii is the total number of tRNA isotypes that pair with the ith codon, tGCNij is the 
numer of copies of the jth tRNA isotype genes in the genome that pair with the ith 
codon, and Sij is a selective constraint on the efficiency of the codon–anticodon 
coupling. Second, the relative adaptiveness value wi of the ith codon was calculated: 
𝑤𝑤𝑤𝑤 = �𝑊𝑊𝑖𝑖/𝑊𝑊𝑚𝑚𝑚𝑚𝑚𝑚𝑛𝑛    𝑤𝑤𝑖𝑖 𝑊𝑊𝑤𝑤 ≠ 0
𝑤𝑤𝑚𝑚𝑚𝑚𝑚𝑚𝑛𝑛           𝑤𝑤𝑖𝑖 𝑊𝑊𝑤𝑤 = 0  
where Wmax is the maximum Wi value and wmean is the geometric mean of 
all wi with Wi ≠ 0. Finally, tAI was calculated as the geometric mean of the relative 
adaptiveness values of all codons in a vlsE variant: 
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tAI = (�𝑤𝑤𝑖𝑖𝑛𝑛
𝑖𝑖=1
)1/𝑛𝑛 
where n is the total number of codons in a vlsE variant. 
2.3. Results 
2.3.1. Effect of altering the nucleotide identities observed in the variable sites 
The maximum-likelihood stationary distribution of the four types of nucleotides was 
estimated at the unexpressed cassettes in each of the seven Borrelia genotypes 
respectively. The maximum likelihood stationary distributions of nucleotides were not 
significantly different from the observed distribution of nucleotides in the unexpressed 
cassettes of any of the seven genotypes (Table 2-2).  
The nucleotide identities observed in variable sites of the unexpressed cassettes of natural 
strains result in the greatest sequence divergence, translational ability, and translational 
efficiency in VlsE variants. Changing nucleotides at the sites that are naturally 
polymorphic among the unexpressed cassettes (δNuc) reduced the sequence divergence 
among VlsE variants as well as the translational ability and translational efficiency of the 
variants (Figure 2-2). The reduction in sequence divergence, translational ability, tRNA 
gene copy number and tRNA adaptation index due to nucleotide alterations were 
statistically significant (p<0.05) in all genotypes except for tRNA gene copy number in 
BoI26 and tRNA adaptation index in 29805 when nucleotides are sampled from the 
maximum likelihood stationary distribution, as well as tRNA adaptation index in 29805 
and zs7 when nucleotide types are sampled from a uniform distribution.  
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 Frequency A Frequency T Frequency G Frequency C p (chi-square) 
B31 (ML) 0.25174 0.24123 0.40096 0.10607 >0.99 
B31 (OB) 0.26222 0.23898 0.38755 0.11125 
JD1 (ML) 0.26558 0.24924 0.37682 0.10836 >0.99 
JD1 (OB) 0.26032 0.25714 0.37490 0.10764 
WI9123 (ML) 0.29318 0.21727 0.38468 0.10487 >0.99 
WI9123 (OB) 0.27846 0.22986 0.38887 0.10281 
29805 (ML) 0.21181 0.28739 0.38064 0.12016 0.98 
29805 (OB) 0.21976 0.27708 0.37411 0.12905 
Bol26 (ML) 0.24390 0.27059 0.37647 0.10904 0.99 
Bol26 (OB) 0.23457 0.27132 0.37353 0.12059 
Zs7 (ML) 0.25265 0.23737 0.39438 0.11559 0.99 
Zs7 (OB) 0.26279 0.23704 0.38718 0.11299 
B. afzelii (ML) 0.25697 0.24668 0.38509 0.11125 0.96 
B. afzelii (OB) 0.23912 0.26598 0.38075 0.11415 
 
Table 2-2. Maximum likelihood (ML) and observed (OB) nucleotide frequencies at the 
vls loci in seven genotypes of Borrelia used in the study 
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Figure 2-2. Changes in sequence divergence, translational ability, tRNA gene copy 
number and tRNA adaptation index of VlsE variants after altering the identities of the 
variable nucleotides in unexpressed cassettes (δNuc). The y-axis shows difference in 
sequence divergence (A1, A2), translational ability (B1, B2), tRNA gene copy number 
(C1, C2) and tRNA adaptation index (D1, D2) from the values of VlsE variants generated 
by the natural unexpressed cassettes after perturbing the variable nucleotides by sampling 
nucleotides randomly (A1, B1, C1, D1) or from a maximum-likelihood stationary 
distribution (A2, B2, C2, D2). Negative values on the y- axis mean a reduction after 
perturbation; zero means no change after perturbation. Each datapoint corresponds to the 
mean of 500 vlsE variants generated from one iteration of the perturbation model. Error 
bars represent 95% confidence intervals of the mean.  
 
2.3.2. Effect of altering the positions of the variable sites 
Altering the positions of the variable sites in the variable regions of the cassettes (δPos) 
resulted in a reduction in the translatability and translational efficiency of VlsE variants 
compared to the VlsE variants generated from the natural unexpressed cassettes in all 
analyzed strains (Figure 2-3B1, 2-3B2, 2-3C1 and 2-3C2). However, regardless of how 
the nucleotides were sampled to generate the perturbed cassettes, the translational ability 
of VlsE variants produced from the cassettes with altered variable locations was 
significantly lower than VlsE variants produced from cassettes with altered nucleotides 
(δNuc) in only two of the seven genotypes (WI9123 and Bol26), tRNA gene copy 
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number was significantly lower in only two of the seven genotypes (29805 and B. afzelii) 
and tRNA adaptation index was significantly lower in five of the seven genotypes (B31, 
JD1, 29805, BoI26 and B. afzelii) (Figure 2-2B1, 2-2B2, 2-2C1, 2-2C2, 2-3B1, 2-3B2, 2-
3C1, 2-3C2). Thus, it is not apparent that altering the positions of the variable sites 
compounds the reduction in translational ability and efficiency of VlsE variants caused 
by altering the nucleotides alone. It is important to note that altering the positions of the 
variable sites must be accompanied by alterations in nucleotides, resulting in a reduction 
in power to detect effects of the position of the variable sites on translational ability and 
translational efficiency of VlsE variants independent of the large effect of nucleotide 
identity. 
Sequence divergence among VlsE variants generated from the unexpressed cassettes with 
computationally altered positions of variable sites (δPos) was significantly lower than the 
variants produced by the natural cassettes in five of the seven strains (B31, JD1, 29805, 
zs7 and B. afzelii) (Figure 2-3A1 and 2-3A2). However, the divergence among VlsE 
variants generated from cassettes with positionally altered variable sites (δPos) was 
significantly lower than the difference produced from altering the nucleotide type (δNuc) 
in none of the seven genotypes (Figure 2-2A1, 2-2A2, 2-3A1 and 2-3A2). Thus, altering 
the positions of the variable sites does not cause a greater reduction in sequence 
divergence than altering the nucleotide identities alone. Further, alteration of the position 
of variable sites in one genotype (Bol26) resulted in a significantly greater sequence 
difference of the VlsE variants than the variants produced from the natural cassettes. 
Although the potential for VlsE variant diversity was significantly elevated by altering 
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the positions of the variable sites in this strain, the sequences in the expression site that 
resulted from these recombination events had low translational ability and efficiency 
(Figure 2-3B1, 2-3B2, 2-3C1 and 2-3C2) which are likely to constrain changes in the 
location of the variable sites.  
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Figure 2-3. Changes in sequence divergence, translational ability, tRNA gene copy 
number and tRNA adaptation index of VlsE variants after altering the positions of the 
variable sites in unexpressed cassettes (δPos). The y-axis shows difference in  sequence 
divergence (A1, A2), translational ability (B1, B2), tRNA gene copy number (C1, C2) 
and tRNA adaptation index (D1, D2) from the values of VlsE variants generated by the 
natural unexpressed cassettes after perturbing the positions of the variable sites. 
Nucleotides at the relocated variable sites were sampled randomly (A1, B1, C1, D1) or 
from a maximum-likelihood stationary distribution (A2, B2, C2, D2). Negative values on 
the y- axis mean a reduction after perturbation; zero means no change after perturbation. 
Each datapoint corresponds to the mean of 500 vlsE variants generated from one iteration 
of the perturbation model. Error bars represent 95% confidence intervals of the mean.  
 
2.3.3. Effect of altering the locations of insertion/deletion mutations 
The locations of insertion/deletion mutations strongly affect the translational ability of 
VlsE variants. Altering the location of all variable sites, including those with 
insertion/deletion variants, significantly decreases translational ability compared to both 
the VlsE variants produced by the natural cassettes and the variants produced by cassettes 
with altered locations of variable sites (δPos) (Figure 2-3B1, 2-3B2 and 2-4B). The 
decreases in translational ability are dramatic, with as many as half of the variants 
containing at least one stop codon (Figure 2-4B). The VlsE variants also show 
significantly lower sequence divergence and lower translational efficiency than those 
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generated by the natural unexpressed cassettes in all strains (Figure 2-4A and 2-4C). 
These results indicate that the patterns of insertion/deletion occurrence are strongly 
constrained by sequence divergence, translational efficiency, and especially translational 
ability.  
 
  
Figure 2-4. Changes in sequence divergence, translational ability, tRNA gene copy 
number and tRNA adaptation index of VlsE variants after perturbing the 
insertion/deletion mutations in unexpressed cassettes (δInDel). The y-axis shows 
difference in sequence divergence (A), translational ability (B), tRNA gene copy number 
(C) and tRNA adaptation index (D) from the values of VlsE variants generated by the 
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natural unexpressed cassettes after perturbing the insertion/deletion mutations. Negative 
values on the y- axis means a reduction after perturbation; zero means no change after 
perturbation. Each datapoint corresponds to the mean of 500 vlsE variants generated from 
one iteration of the perturbation model. Error bars represent 95% confidence intervals of 
the mean.  
 
2.4. Discussion 
Antigenic variation systems experience strong selection to evade the rapidly changing 
and lethal host immune environment. Thus, there is a premium for ever greater antigenic 
divergence among protein variants generated by antigenic variation systems. However, 
divergence among antigenic variants as well as the organization of the antigenic variation 
system as a whole can be constrained by selection for basic molecular functions such as 
translational ability or translational efficiency. The computational analyses presented here 
demonstrate that the vls antigenic variation system that generates antigenic diversity in 
natural strains of Bb during infections of vertebrate hosts is shaped by forces of natural 
selection acting on greater antigenic divergence, translational ability, and translational 
efficiency. 
Bb strains generate antigenically distinct protein variants by recombining segments of 
diverse, homologous, unexpressed cassettes into the expression site of the antigen. In all 
natural strains analyzed, the sequence divergence among expressed proteins, as well as 
the translational ability and translational efficiency of those proteins, is highest by using 
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the nucleotides observed at the sites that are variable among the unexpressed cassettes. 
Altering the nucleotides used at these sites can reduce the sequence divergence, introduce 
stop codons, and reduce the elongation rate by using non-preferred codons. Although 
many of the Bb genomic codons are chosen because of mutational biases or replicational 
selection and are not optimized for translation [54], our results show that codon usage in 
vlsE is selected for translational efficiency. Codon optimality may be particularly 
important to the elongation rates and translational accuracy of VlsE variants as there are 
many variable codons that are tandemly arrayed in the unexpressed cassettes. Tandem 
codons using non-preferred codons can act synergistically to reduce translational rate and 
accuracy [55, 56]. A hypothesized function of the VlsE protein, to protect other surface-
exposed proteins from antibodies by hiding these potential antigens [21], requires highly 
expressed and accurately translated proteins for appropriate antigenicity. It is worth 
noting that, although the statistical difference in codon optimality between natural and 
perturbed cassettes is consistent across Bb strains, the quantitative influence of such 
difference on VlsE concentration is not tested and beyond the scope of this thesis. Future 
analysis in the translational dynamics of VlsE may shed light on this question.  
Altering the position of the variable sites within the variable regions significantly reduced 
both the translational ability and translational efficiency of VlsE variants generated. The 
sequence divergence of VlsE variants generated from positionally altered cassettes, 
however, was significantly lower than that from the natural cassettes in only five of the 
seven strains. Further, divergence among the VlsE variants generated after altering the 
positions of the variable sites in one strain (Bol26) was significantly greater than those 
generated from the natural cassettes. Strain BoI26 is a unique case where many codons 
30 
 
contained multiple variable nucleotides. These variable sites become separated on 
different codons after positional perturbation, leading to greater amino-acid-level 
divergence after recombination.  
The organization and identity of variable sites in the unexpressed cassettes of natural 
strains resulted in high amino acid divergence among the VlsE variants, suggesting that 
the sequences of the unexpressed cassettes observed in natural strains strongly promotes 
antigenic divergence. Amino acid sequence difference among antigens is negatively 
correlated with cross-reactivity with polyclonal antibodies [25, 46, 47]. This reduction in 
binding affinity to antibodies is crucial for immune evasion and longevity of Bb in 
infected hosts, a key factor in the fitness of Bb. Although altering the positions of variable 
sites in one strain (Bol26) increases sequence differences of the VlsE variants, which may 
provide greater ability to evade the immune response, many of these VlsE variants 
contained stop codons, frameshifts, and low translational efficiency. Therefore, the 
potential advantage of greater antigenic diversity is likely constrained by selection for 
efficient expression of functional proteins.  
Perturbing both nucleotide identities and the positions of variable sites did not result in a 
greater reduction in antigenic divergence, translational ability, and translational efficiency 
of VlsE variants than altering only the nucleotide identities. Although the positions of the 
variable sites in the unexpressed cassettes may be selectively important, the absence of an 
observed effect may be attributed to two factors. First, the positions of variable sites 
cannot be altered without also altering the nucleotides at those positions. Thus, the effect 
of the position of the variable sites cannot be disentangled from the effects of nucleotide 
identities at these sites, resulting in low statistical power to detect the effect of the 
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variable positions. Second, the positions of variable sites might be important for traits 
that were not evaluated. For example, amino acids at the positions that are naturally 
variable may be more antigenic than those at other positions or may impact the three 
dimensional structure of VlsE.  
Length differences among unexpressed cassettes occur almost exclusively in triplets in all 
natural strains, resulting in very low levels of frameshift mutations during recombination. 
The triplet pattern of insertion/deletion mutations may result from slipped-strand 
mispairing induced by trinucleotide repeats that are common in the variable regions of all 
strains [27]. The δInDel algorithm, however, randomized the locations of 
insertion/deletion mutations, disrupting the triplets and dramatically increasing the rate of 
frameshift mutations in the VlsE variants. These frameshift mutations result in a large 
number of premature stop codons in vlsE. This observation is consistent with the 
hypothesis that natural selection can increase off-frame stop codons because they prevent 
resource waste and potentially cytotoxic products when frameshifts occur [57]. 
In recombination-based antigenic variation systems, the genetic sequences of the 
unexpressed cassettes determine the possible degree of diversity among antigenic variants 
during a host infection. The analyses presented in this chapter demonstrate that the vls 
antigenic variation systems of Bb is organized to promote antigenic divergence among 
proteins variants without significantly sacrificing translational ability and translational 
efficiency. The selection on translational properties in unexpressed regions was 
statistically significant and in some cases appeared to constrain the selection for greater 
antigenic diversity. These analyses identified properties of the antigenic variation system 
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that appear to be under selective constraints which can be experimentally investigated in 
future studies. The selection pressures described here could be common in the diverse 
range of pathogens that generate antigenic variants by intragenomic recombination such 
as Neisseria gonorrhoeae and Mycoplasma synoviae [34, 35]. In these pathogens, similar 
computational analyses to those conducted in this study can be used to establish the sets 
of selection pressures that affect the evolution of unexpressed cassettes.  
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Chapter 3. Predicted effects of VlsE diversity on Borrelia 
burgdorferi dynamics within hosts  
3.1. Introduction 
Lyme disease is the most commonly reported tick-borne illness in North America. The 
causative agent, Borrelia burgdorferi (Bb), establishes long-term, multisystemic 
infections despite active adaptive immune responses from vertebrate hosts [18, 58]. Bb 
evades host immune responses through multiple mechanisms including the vital and well-
characterized vls antigenic variation system [18]. The vls antigenic variation system alters 
the sequence of the immunodominant surface-exposed antigen, VlsE, resulting in VlsE 
sequence diversity within hosts [18, 19]. Subpopulations of Bb with altered VlsE 
sequences evade antibody recognition, thus permitting the characteristic long-term 
infections [18, 22-24, 38, 39]. The quantitative effect of the generation of VlsE diversity on 
the probability of immune evasion or on Bb population sizes within hosts has not been 
investigated.  
The within-host population dynamics of Bb are controlled by the adaptive immune 
response. In immunocompetent mice, Bb rapidly proliferates in the initial phases of the 
infection before inducing a strong antibody response against several surface exposed 
proteins [59], predominantly VlsE, around day 7 of the infection, leading to a rapid 
reduction in abundance [60]. Yet, Bb is rarely cleared in immunocompetent mice likely 
due to the down regulation of most surface exposed antigens and the antigenic variation 
generated at VlsE [18, 60]. The degree of diversity among VlsE variants expressed in the 
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Bb population is expected to be essential to avoiding clearance by the antibody response 
of the host [20, 27]. Evolutionary studies demonstrated that natural selection selects for 
greater potential to generate diversity at VlsE and that the variable sites within the 
cassettes are organized to maximize diversity among VlsE variants [27, 61]. Yet it 
remains unclear how the diversity among VlsE variants facilitates within-host persistence 
or affects Bb population dynamics within hosts.  
In this study, we investigated the effects of antigenic diversity at VlsE on the population 
dynamics of Bb within infected hosts. The population dynamic models were 
parameterized using relevant experimental data and the results were compared to data on 
Bb population dynamics of Bb from experimental infections. Importantly, we compared 
the effect of a strain’s ability to generate diversity at VlsE on the population dynamics of 
the pathogen. In addition, the models make predictions that can be experimentally tested 
to estimate the likelihood of mechanisms described in the models.  
3.2. Materials and Methods 
3.2.1. Dynamic model 
The dynamic model used to assess Bb population dynamics incorporates the presence and 
abundance of each VlsE variant as well as the specificities, affinities and abundances of 
antibodies. Bb population dynamics - including growth, recombination and immune 
clearance - are described by: 
𝑑𝑑𝑑𝑑𝑑𝑑(𝑖𝑖)
𝑑𝑑𝑑𝑑
= 𝜔𝜔𝜔𝜔𝐵𝐵𝐵𝐵(𝑤𝑤) �1 − ∑ 𝑑𝑑𝑑𝑑(𝑖𝑖)𝑖𝑖
𝐾𝐾
� − 𝑟𝑟𝐵𝐵𝐵𝐵(𝑤𝑤) − 𝜇𝜇 × 𝐴𝐴𝐵𝐵𝑟𝑟𝐴𝐴𝑛𝑛(𝑤𝑤)𝐵𝐵𝐵𝐵(𝑤𝑤) + 𝜈𝜈𝐵𝐵𝐵𝐵∗(𝑤𝑤)  eq. 3.1 
𝑑𝑑𝑑𝑑𝑑𝑑∗(𝑖𝑖)
𝑑𝑑𝑑𝑑
= 𝜇𝜇 × 𝐴𝐴𝐵𝐵rxn(𝑤𝑤)𝐵𝐵𝐵𝐵(𝑤𝑤) − 𝜈𝜈𝐵𝐵𝐵𝐵∗(𝑤𝑤) − 𝑟𝑟𝐵𝐵𝐵𝐵∗(𝑤𝑤) − 𝜌𝜌𝐵𝐵𝐵𝐵∗(𝑤𝑤)   eq. 3.2 
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Such that Bb expressing VlsE variant type i (Bb(i)) grows logistically with an intrinsic 
growth rate β. Antibody-independent immune effects are described as an adjustment in 
the growth rate by a factor ω. A carrying capacity K for the Bb population is estimated 
from in vitro growth data [62]. Bb(i) recombines with the unexpressed vls cassettes at rate 
r. Bb(i) interacts with antibodies at association rate μ. Abrxn(i) represents the binding 
capacity of all antibodies present in the system to Bb(i) and is a function of the 
concentration of each type of antibody, corrected by the specificity of that antibody for 
the VlsE variant, summed across all antibodies present (detailed in 3.2.1.3). Bb(i) 
transitions to the susceptible state Bb*(i) when bound by an antibody, which is then 
removed by the immune system at constant rate ρ. Bb*(i) can dissociate from antibodies 
at rate ν.  
3.2.1.1 Antigenic variation by recombination 
Bb infecting immunocompetent mice remain at densities much lower than the carrying 
capacity due to the host antibody responses [60]. However, Bb are not eliminated due to 
the sequence changes in VlsE introduced by recombination, which reduces antibody 
killing efficacy. Pairwise sequence similarity between VlsE variants is expected to be a 
function of the sequence diversity among the vls cassettes that recombine into vlsE and 
the number of recombination events that have occurred since the variants shared a 
common ancestor. We estimated the distribution of pairwise sequence similarities 
between VlsE variants by simulating recombination between vls cassettes and VlsE. To 
do this, we first generated 1000 vlsE parental variants (vlsEn). Each parental variant was 
generated by simulating 100 sequential recombination events starting from the vlsE 
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sequence of Bb clone 5A3, as described in Chapter 2.2.3. From each of the 1000 parental 
vlsEn sequences, we simulated 20 daughter sequences (vlsE1n-vlsE20n) that experienced 
between 1 and 20 recombination events in order to estimate sequence similarity between 
vlsE variants as a function of the number of recombination events (Dr). Pairwise 
sequence similarity between each VlsEn and each of its daughter sequences (VlsE1n-
VlsE20n) was calculated as amino acid sequence identity. The expectation (M(Dr)) and 
variance (𝜎𝜎(Dr)) in sequence similarities between VlsE variants separated by Dr 
recombination events was calculated as the mean and standard deviation of the 1000 
sequence similarity values for each value of Dr.  
Two sets of vls unexpressed cassettes were used to estimate the distribution of pairwise 
sequence similarities between VlsE variants: the natural vls unexpressed cassettes 
observed in Bb clone 5A3 and a set of unexpressed cassettes generated in silico by 
altering the nucleotides at the variable sites as described in 2.2.2.1. The in silico 
generated unexpressed cassettes produces VlsE variants with lower diversity than the 
natural unexpressed cassettes.  
3.2.1.1.2. Sequence similarities among VlsE variants within infections  
In the model of Bb population dynamics, recombination between vlsE and the 
unexpressed vls cassettes results in a novel vlsE variant, similar to an infinite alleles 
model. Each new vlsE variant can be represented by a node in a tree graph, connected to 
its direct parental vlsE by one edge. The number of recombination events (Dr) between 
VlsE variants i and j is equivalent to the number of edges connecting the nodes 
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representing variants i and j. For VlsE variants i and j that are separated by over 20 
recombination events, Dr is set to 20. This approximation utilizes the diminishing effect 
of recombination events (Dr) on sequence similarity (section 3.3.5). Sequence similarities 
between VlsE variant type i and j (S(i,j)) within an infection are determined by sampling 
from the distribution of pairwise sequence similarities conditional on Dr:  
𝑃𝑃(𝑆𝑆(𝑤𝑤, 𝑗𝑗)|𝐷𝐷𝑟𝑟) = 𝑡𝑡(𝛭𝛭(𝐷𝐷𝑟𝑟),𝜎𝜎(𝐷𝐷𝑟𝑟)2) = 1
𝜎𝜎√2𝜋𝜋
𝑒𝑒
−(𝑆𝑆(𝑖𝑖,𝑗𝑗)−𝛭𝛭(𝐷𝐷𝐷𝐷))2
2𝜎𝜎(𝐷𝐷𝐷𝐷)2     eq. 3.3 
The sequence similarities among variants created by recombination are relevant to the 
degree of reactivity of antibodies specific to variant i have for variant j. 
3.2.1.2 Antibody kinetics 
The concentration of antibodies targeting VlsE variants was modeled similar to 
Michaelis-Menten kinetics [62, 63]. Antibodies specifically targeting VlsE variant type i 
are triggered when the abundance of the Bb(i) subpopulation is greater than 1000 
individuals. The magnitude of the antibody response that is specific to VlsE type i 
(Abspecific(t,i)) is estimated by:  
𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝑒𝑒𝐴𝐴𝑤𝑤𝑖𝑖𝑤𝑤𝐴𝐴(𝑡𝑡, 𝑤𝑤) = � 0                                       𝑡𝑡 − 𝑡𝑡𝑑𝑑𝑡𝑡𝑖𝑖𝑡𝑡 < 𝛥𝛥𝑡𝑡𝑙𝑙𝑚𝑚𝑡𝑡
𝐴𝐴𝑑𝑑𝑚𝑚𝑚𝑚𝑚𝑚 ( 𝑑𝑑−𝑑𝑑𝑡𝑡𝐷𝐷𝑖𝑖𝑡𝑡−𝛥𝛥𝑑𝑑lag)𝑛𝑛 𝑑𝑑1/22 +(𝑑𝑑− 𝑑𝑑𝑡𝑡𝐷𝐷𝑖𝑖𝑡𝑡−𝛥𝛥𝑑𝑑lag)𝑛𝑛         𝑡𝑡 − 𝑡𝑡𝑑𝑑𝑡𝑡𝑖𝑖𝑡𝑡 > 𝛥𝛥𝑡𝑡lag                 eq. 3.5 
When ∑ 𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝑒𝑒𝑤𝑤𝐴𝐴𝑤𝑤𝑖𝑖𝐴𝐴(𝑡𝑡, 𝑤𝑤) ≤ 𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝐴𝐴𝑖𝑖  
Where ttrig is the time when the antibody specific to variant type i is triggered. If the sum 
of the concentrations of all antibody types exceeds the experimentally observed 
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maximum antibody concentration (Abmax) [63, 64], the concentration of each antibody 
type was normalized to Abmax. 
𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝑒𝑒𝐴𝐴𝑤𝑤𝑖𝑖𝑤𝑤𝐴𝐴(𝑡𝑡, 𝑤𝑤) = 𝐴𝐴𝐵𝐵(𝑡𝑡) 𝐴𝐴𝑑𝑑𝐴𝐴𝐴𝐴𝑚𝑚𝐴𝐴𝑖𝑖𝐴𝐴𝑖𝑖𝐴𝐴(𝑑𝑑,𝑖𝑖)
∑ 𝐴𝐴𝑑𝑑𝐴𝐴𝐴𝐴𝑚𝑚𝐴𝐴𝑖𝑖𝐴𝐴𝑖𝑖𝐴𝐴(𝑑𝑑,𝑖𝑖)𝑖𝑖                eq. 3.6 
When ∑ 𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝑒𝑒𝑤𝑤𝐴𝐴𝑤𝑤𝑖𝑖𝐴𝐴(𝑡𝑡, 𝑤𝑤) > 𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝐴𝐴𝑖𝑖  
3.2.1.2.1 Immunodominant antibody kinetics 
A potential constraint on antibody dynamics is the number of types of antibodies that can 
be induced per unit of time. Although the naïve antibody repertoire is highly 
heterogeneous, only a small subset of the B cell clones will proliferate significantly 
during an infection - a well-characterized phenomenon called antibody 
immunodominance [25, 65]. We extended the dynamics model to include antibody 
immunodominance to account for this constraint. For the sake of simplicity, we allowed 
only one immunodominant antibody type to be actively produced at a given time. The 
type of antibody that was activated was chosen based on the relative abundance of the 
corresponding VlsE variant. 
Each dominant antibody is actively produced for Td hours before the next type of 
dominant antibody was allowed to expand, eventually replacing the previous dominant 
antibody. The dynamics of each type of dominant antibody was described by: 
𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝑒𝑒𝐴𝐴𝑤𝑤𝑖𝑖𝑤𝑤𝐴𝐴j(𝑡𝑡, 𝑤𝑤) =
⎩
⎪
⎨
⎪
⎧
    0                                                                       𝑡𝑡 − 𝑡𝑡𝑑𝑑𝑡𝑡𝑖𝑖𝑡𝑡 < 𝛥𝛥𝑡𝑡la𝑡𝑡
𝐴𝐴𝑑𝑑𝑚𝑚𝑚𝑚𝑚𝑚 ( 𝑑𝑑−𝑑𝑑𝑡𝑡𝐷𝐷𝑖𝑖𝑡𝑡−𝛥𝛥𝑑𝑑la𝑡𝑡)𝑛𝑛 𝑑𝑑1/22 +(𝑑𝑑− 𝑑𝑑𝑡𝑡𝐷𝐷𝑖𝑖𝑡𝑡−𝛥𝛥𝑑𝑑la𝑡𝑡)𝑛𝑛                       𝛥𝛥𝑡𝑡𝑙𝑙𝑚𝑚𝑡𝑡  ≤ 𝑡𝑡 − 𝑡𝑡𝑑𝑑𝑡𝑡𝑖𝑖𝑡𝑡 < 𝑇𝑇𝑇𝑇
𝐴𝐴𝑑𝑑𝑚𝑚𝑚𝑚𝑚𝑚 ( 𝑑𝑑−𝛥𝛥𝑑𝑑la𝑡𝑡)𝑛𝑛 𝑑𝑑1/22 +(𝑑𝑑−𝛥𝛥𝑑𝑑la𝑡𝑡)𝑛𝑛 − 𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝑒𝑒𝐴𝐴𝑤𝑤𝑖𝑖𝑤𝑤𝐴𝐴𝑖𝑖+1(𝑡𝑡, 𝑤𝑤)        𝑡𝑡 − 𝑡𝑡𝑑𝑑𝑡𝑡𝑖𝑖𝑡𝑡 ≥ 𝑇𝑇𝑇𝑇       eq. 3.11 
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Where Abspecificj represents the concentration of the jth activated immunodominant 
antibody. 
3.2.1.3 Antibody effects on Bb dynamics  
Specific and non-specific but cross-reactive antibodies negatively impact the abundance 
of Bb. The quantitative impact of antibodies specific to VlsE variant j on the dynamics of 
Bb expressing VlsE variant i is a function of the abundance of antibody j (Abspecific(t,j)) 
and the degree of cross-reactivity between antibody j and VlsE variant i (f(S(i,j))). The 
degree of cross reactivity between antibody j and VlsE variant i is dependent on the 
similarity between VlsE types i and j: 
𝐴𝐴𝐵𝐵𝑟𝑟𝐴𝐴𝑛𝑛(𝑡𝑡, 𝑤𝑤) = ∑ 𝐴𝐴𝐵𝐵𝐴𝐴𝐴𝐴𝑒𝑒𝐴𝐴𝑤𝑤𝑖𝑖𝑤𝑤𝐴𝐴(𝑡𝑡, 𝑗𝑗) 𝑖𝑖(𝑆𝑆(𝑤𝑤, 𝑗𝑗))𝑖𝑖      eq. 3.7 
Where 𝑖𝑖(𝑆𝑆(𝑤𝑤, 𝑗𝑗)) is a function that modulates antibody reactivity via the sequence 
similarity between the VlsE variants i and j. By definition, this function should satisfy 
f(1)=1 and f(0)=0. For simplicity, cross-reactivity is modeled using a power function. 
𝑖𝑖�𝑆𝑆(𝑤𝑤, 𝑗𝑗)� = 𝑆𝑆(𝑤𝑤, 𝑗𝑗)𝑥𝑥         eq. 3.8 
Where larger values of x correspond to higher antibody specificity and lower cross-
reactivity. 
3.2.1.4 The immune effector cells 
The rate at which antibody-bound Bb cells are eliminated depends on the concentration 
of immune effector cells such as phagocytes [62]. Therefore, population dynamics of 
immune effector cells may also affect Bb population dynamics. Immune effector cell 
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dynamics are modeled similarly to Binder et al [62]. Immune effector cells are assumed 
to behave qualitatively similar to phagocytes in the sense that they have an intrinsic 
migration rate, a recruitment rate in response to the presence of antigens, and an intrinsic 
death rate: 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= 𝜙𝜙 + 𝜓𝜓∑ (𝑑𝑑𝑑𝑑(𝑖𝑖)+𝑖𝑖 𝑑𝑑𝑑𝑑∗(𝑖𝑖))
∑ (𝑑𝑑𝑑𝑑(𝑖𝑖)+𝑖𝑖 𝑑𝑑𝑑𝑑∗(𝑖𝑖))+𝐶𝐶𝑀𝑀 − 𝜃𝜃𝑀𝑀      eq. 3.9 
Where 𝜙𝜙 is the intrinsic rate of recruitment of immune effectors to an infection sites; 𝜓𝜓 is 
the recruitment rate of immune effectors in response to infection; 𝜃𝜃 is the death rate of 
the immune effectors; and C is the number of Bb that corresponds to half maximum 
recruitment rate.  
When immune effector cell dynamics are included in the model, eq. 3.2 becomes: 
𝑑𝑑𝑑𝑑𝑑𝑑∗(𝑖𝑖)
𝑑𝑑𝑑𝑑
= 𝜇𝜇 × 𝐴𝐴𝐵𝐵𝑟𝑟𝐴𝐴𝑛𝑛(𝑤𝑤)𝐵𝐵𝐵𝐵(𝑤𝑤) − 𝜈𝜈𝐵𝐵𝐵𝐵∗(𝑤𝑤) − 𝑟𝑟𝐵𝐵𝐵𝐵∗(𝑤𝑤) − 𝜌𝜌0𝐵𝐵𝐵𝐵∗(𝑤𝑤)𝑀𝑀  eq. 3.10 
Where the rate of removal of the antibody-bound Bb follows the law of mass action. 
3.2.2. Numerical simulation based on the dynamics model 
Bb population dynamics were simulated numerically to allow stochastic events to impact 
the qualitative and quantitative outcomes of the system. Parameter values used in 
numerical simulation were estimated based on literature or by fitting experimental 
observations to minimize the sum of squared errors between observations and predictions. 
The numerical simulation was repeated 20 times with each set of parameter values. 
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3.3. Results 
3.3.1. Bb dynamics cannot be explained by the dynamics model without including 
antibody immunodominance or dynamics of immune effector cells 
Regardless of the parameters used, the Bb population dynamics observed in experimental 
infections could not be replicated using the simple population dynamic model that does 
not explicitly account for either antibody immunodominance or for immune effector cell 
dynamics. Simulations across the simple model using either low removal rates of 
antibody-coated Bb (ρ) or high antibody specificity (x) permitted persistent infections but 
the dramatic decline in Bb population densities observed in experimental infections after 
the initial proliferation could not be reproduced (Figure 3-1). By contrast, high removal 
rates or low antibody specificity recreated the rapid decrease in population densities after 
the initial proliferation but populations were consistently eliminated from the host (Figure 
3-1). Parameter values used for numerical simulation are listed in Table 3-1. 
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Figure 3-1. Numerical simulations of the Bb population dynamic models that did not 
include antibody immunodominance nor immune effector cell dynamics could not 
reproduce experimental time series of Bb population dynamics in mice. Bb population 
dynamics are simulated with different values of the removal rate (ρ) and antibody 
specificity (x). Open circle, Bb levels experimentally observed by Pahl et al. [60].  
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Parameter Unit Value Derived from Description 
β hour−1 0.06 [66] Bacterial growth rate 
K cells 150000 [60] Bacterial carrying capacity 
𝜌𝜌0 cells−1 hour−1 0.0082 [62] Immune effector cells killing rate 
Abmax μg ml−1 8.5 [59] Maximum total antibody 
concentration 
ω - 0.9 Estimated Decrease in bacterial growth rate 
due to Innate immune effect 
r hour−1 0.0059 [20] Recombination rate 
µ ml μg−1 hour−1 0.0085 [62] Antibody association rate 
𝜈𝜈 hour−1 1 [62] Antibody dissociation rate 
𝛥𝛥𝑡𝑡𝑙𝑙𝑚𝑚𝑡𝑡 hour 72 [63] Time until antibody response starts x - 7.5(immune effector 
dynamics) 
2.25(antibody 
immunodominance) 
Estimated Antibody specificity 
𝜙𝜙 cells hour−1 0.1 [62] Intrinsic recruitment rate of 
immune effector cells 
𝜓𝜓 hour−1 0.025 Estimated Bb-dependent recruitment rate of 
immune effector cells 
𝑡𝑡 cells 35000 Estimated Bb population size that yields half-
maximal recruitment of immune 
effector cells 
𝜃𝜃 hour−1 0.08 [67] Immune effector cells death rate 
𝑇𝑇𝑇𝑇 hour 360 Arbitrary Time when one type of antibody is 
dominantly expressed 
 
Table 3-1. Parameters used in the numerical simulations. 
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3.3.3. Including antibody immunodominance in the model can account for 
experimentally observed Bb population dynamics within hosts  
The Bb dynamics observed in experimentally infected mice can be reproduced by 
including immunodominance - where only one type of antibody is actively expressed at a 
time - into the population dynamic model (Table 3-1). Bb populations rapidly increase in 
density followed by a dramatic decline caused by antibodies specific to the parental VlsE 
variant (Figure 3-2A). However, a sufficient number of recombinant VlsE variants are 
different enough from the parental VlsE to allow continued persistence in the host, 
similar to the observed data. The relative abundance of Bb cells expressing the parental 
VlsE decreased rapidly following the specific antibody response as was observed in 
experimentally infected mice (Figure 3-2B). The predicted Bb population dynamics and 
VlsE variant dynamics that most closely resembled the empirical data from experimental 
infections assumed that antibody specificity was related to sequence diversity as 
𝑆𝑆(𝑤𝑤, 𝑗𝑗)2.25 (Table 3-1).  
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Figure 3-2. Numerical simulation of Bb population dynamics with antibody 
immunodominance included in the model can reproduce the experimental time series. (A) 
The Bb population dynamics predicted by the model that includes antibody 
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immunodominance replicates the data from experimental infections. Open circle, Bb 
levels experimentally observed by Pahl et al. [60]. (B) Additionally, the proportion of Bb 
cells retaining the parental VlsE sequences predicted by the numerical simulation was 
similar to the proportion retaining the parental sequence in experimental infections 
observed by Coutte et al. [20] in C3H mice (open circles).  
 
The mean antibody pressure (Abrxn) across extant VlsE variants differed considerably 
between the models that included and excluded immunodominance (Figure 3-3). In the 
models including antibody immunodominance, the average antibody pressure increased 
each time a new type of antibody was generated and declined thereafter as the proportion 
of specific variants declined (Figure 3-3 A), demonstrating a fluctuating and dynamic 
effect on the Bb population. The immunodominant antibody has high affinity to one VlsE 
variant, which is rapidly removed from the population, and distinct affinities to the other 
VlsE variants, resulting in a much larger variance in antibody pressure among VlsE types 
than in models that allow multiple antibodies, each with affinities to different VlsE types, 
simultaneously (Figure 3-3B). Antibody pressure in models that excluded 
immunodominance was remained stable after the initial increase (Figure 3-3A).  
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Figure 3-3. Antibody immunodominance creates temporal variation in antibody pressure 
(𝐴𝐴𝐵𝐵𝑟𝑟𝐴𝐴𝑛𝑛) on Bb within hosts. (A) The mean antibody pressure across all extant VlsE 
variants increases rapidly after the first antibody is expressed (arrow at day 3) in all 
models. If antibody immunodominance is not included, the mean antibody pressure 
remains constant while new antibodies are continuously added. Including 
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immunodominance results in declining mean antibody pressure until the expansion of a 
subsequent antibody (arrow at day 18) causes the mean antibody pressure to increase. (B) 
The difference in the standard deviation in antibody pressure across the extant VlsE 
variants between models that include immunodominance and those that do not is 
dramatic. In models that include immunodominance, variance in antibody pressure 
increases rapidly as the dominant antibody targeting the dominant VlsE variant 
proliferates, then decreases due to the reduction in the density of the dominant VlsE 
variant until the introduction of the subsequent antibody. In models that exclude 
immunodominance, there are many antibodies that each react with each extant VlsE 
variant, such that each VlsE variant experience similar antibody pressure. 
 
3.3.4. Models including immune effector cell dynamics can reproduce the 
experimentally observed Bb dynamics 
Explicitly modeling immune effector cell dynamics, while excluding immunodominance, 
resulted in Bb population dynamics similar to observed experimentally (Figure 3-4A). 
Antibody specificity estimated from the model was very high 𝑆𝑆(𝑤𝑤, 𝑗𝑗)7.5. Similar to the 
models including immunodominance, the relative abundance of Bb cells expressing the 
parental VlsE decreased rapidly following the specific antibody response as was observed 
in experimentally infected mice (Figure 3-4B). The simulation described temporal 
fluctuations in abundances of both Bb populations and of immune effector cells (Figure 
3-4C).  
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Figure 3-4. Numerical simulations of Bb population dynamic models that include 
immune effector dynamics can reproduce the data from experimental infections in mice. 
(A) The Bb population dynamics predicted by the model that includes immune effector 
cell dynamics replicates the data from experimental infections. Open circle, Bb levels 
experimentally observed by Pahl et al. [60]. (B) The proportion of Bb cells retaining the 
parental VlsE sequence predicted by the numerical simulation resembles the data 
observed by Coutte et al. [20] in C3H mice. (C) The predicted dynamics of immune 
effectors is out-of-phase with the Bb abundances, resembling classical predator-prey 
dynamics. 
 
 
3.3.5. VlsE diversity significantly influences Bb levels 
Pairwise sequence similarities among VlsE variants (S(i,j)) generated from the natural vls 
cassettes are significantly lower than those among VlsE variants generated by the 
perturbed vls unexpressed cassettes (Figure 3-5). Pairwise sequence similarities among 
variants generated by both the natural and the perturbed vls unexpressed cassettes are 
negatively correlated with the number of recombination events that separate the variants 
(Dr) (Figure 3-5). Because VlsE contains only a finite number of variable sites, the rate 
of decrease in S(i,j) diminishes over time (Figure 3-5).  
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Figure 3-5. Pairwise sequence similarity (S(i,j)) is greater among VlsE variants generated 
by perturbed than natural vls unexpressed cassettes. Filled circle, VlsE variants generated 
by the natural unexpressed cassettes; open circle, VlsE variants generated by the 
perturbed unexpressed cassettes.  
  
In both the antibody immunodominance and the immune effector dynamics models, 
higher diversity among VlsE variants results in higher Bb density when immune 
suppression impacts Bb population dynamics (Figure 3-6). When Bb population 
abundances are strongly suppressed by antibodies, Bb with the natural cassettes were up 
to 26% more abundant than Bb with the perturbed cassettes in the model that included 
immune effector dynamics. In the model that included antibody immunodominance, Bb 
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with the natural cassettes were up to 200% more abundant than Bb with the perturbed 
cassettes.  
 
 
Figure 3-6. Greater diversity among VlsE variants results in substantially higher densities 
of Bb within hosts. The population dynamics of Bb with natural vls cassettes, and thus 
greater within-host VlsE diversity, were substantially different that the dynamics of Bb 
with perturbed cassettes in simulations that included immune effector dynamics (A) and 
those that included antibody immunodominance (B). The left panels show the dynamics 
of Bb populations with natural (solid lines) and perturbed (dotted line) vls cassettes 
53 
 
during the initial stages of infection. The right panels show the relative difference in 
abundance of Bb populations with natural and perturbed vls unexpressed cassettes.  
 
3.4 Discussion 
A simple model of the Bb population dynamics in the face of antibody pressure cannot 
account for Bb persistence within hosts following the rapid, antibody-mediated decline in 
population sizes observed in experimental infections, regardless of the parameters used in 
the model. These results suggest that mechanisms in addition to VlsE antigenic variation 
may be necessary to explain the persistent within-host survival of Bb or that the efficacy 
of the adaptive immune response wanes quickly in the early stages of infection. 
Alternatively, two well-characterized mechanisms - antibody immunodominance or 
immune effector cell dynamics - can account for the Bb population dynamics observed in 
experimental infections [25, 62]. 
Including either immunodominance or fluctuation in immune effector cell abundances 
into the Bb population dynamic model can replicate the Bb population dynamics 
observed in experimental infections. However, the antibody specificity values (x) 
necessary to recreate the observed dynamics vary between the models. Antibody 
specificity can be relatively mild in the model including immunodominance while the 
model with immune effector cell dynamics required little cross-reactivity to recreate the 
Bb dynamics. Further, the models result in considerably different predictions of 
population dynamics in Bb as well as differences in the effect of VlsE variability on 
within-host Bb abundance. That is, models with antibody immunodominance predicts Bb 
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abundance stabilizes after the early stages of infection, the level of which is largely 
affected by the diversity at VlsE (Figure 3-6), while models including immune effector 
cell dynamics predict continuous fluctuations in Bb abundance with only small effects of 
VlsE diversity occurring only when population sizes are small (Figure 3-6). The 
differences in the predictions of the models can be tested with experimental data to 
estimate the likelihoods of processes occurring within hosts.  
The effect of diversity among VlsE variants on the abundance of Bb within-hosts is most 
apparent at low population densities. Low population density is a sign of strong immune 
suppression, under which the ability to evade immune targeting is vital. Besides, at low 
densities, VlsE sequences experience fewer recombination events per unit time, such that 
high diversity- generating abilities of the unexpressed cassettes are vital for the 
recombinants to be different enough from the parental VlsE to escape the immune 
response. It is surprising, however, that small differences in sequence diversity have a 
large effect on Bb dynamics. For instance, pairwise sequence difference among VlsE 
variants produced by the two sets of unexpressed cassettes explored here differ by less 
than 1% per recombination event, but the resulting difference in Bb abundance differed 
by more than 200% for models that included immunodominance and as much as 26% for 
models that included immune effector dynamics. The differences in Bb abundance likely 
have effects on key evolutionary and pathological traits of Bb such as the probability of 
dissemination to internal organs and the probability of transmission to feeding ticks. 
The mechanisms resulting in the rapid decrease in Bb abundance followed by within-host 
persistence also differ among the models. In the models that include immunodominance, 
a single antibody type can rapidly eliminate the parental VlsE after the specific antibody 
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response is initiated. This causes a rapid decrease in the Bb population that is composed 
primarily of the parental VlsE. However, the lag time needed to initiate the immune 
response allows a sufficient amount of recombination to occur in a fraction of the 
population that is able to evade the antibody targeting the parental VlsE variant. 
Subsequent antibody responses, coupled with the limit amount of recombination 
occurring in the small Bb population, can control the Bb abundances within the host. 
The models that include immune effector dynamics permit persistence due to predator-
prey like dynamics. The recruitment rate of immune effector cells is a function of the 
abundance of Bb leading to elevated killing when Bb level is high and reduced killing 
when Bb is rare [68]. The immune effector dynamics deviate from the pure Lotka-Voltera 
model in that there is an intrinsic rate of recruitment of the immune effector cells, which 
can eliminate Bb at large values.  
The models described in this chapter suggest testable hypotheses that may account for the 
population dynamics of Bb within hosts. However, the quantitative predictions are likely 
affected by several models assumptions. For example, the models were parameterized to 
fit a sparse time series and thus likely suffer from over-fitting. Further, it is likely that 
other unexplored mechanisms could also replicate the observed data assuming reasonable 
parameters. Nevertheless, experimental data can differentiate the likelihoods of the 
mechanisms proposed in each of the explored models given their divergences in 
parameter values as well as the predictions of the relative effect of VlsE diversity on Bb 
abundance.   
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Chapter 4. Correlation between antigenicity and variability 
of amino acid residues in VlsE 
4.1. Introduction 
The continual arms race between host immune responses and antigenic variation of 
microbial parasites results in strong natural selection shaping the molecular interactions 
at the antigen-antibody interface. For example, in the Lyme bacteria Borrelia burgdorferi 
(Bb), continuous alteration of the surface antigen, VlsE, is required for the spirochete to 
escape antibody recognition and establish long-term infections in vertebrate hosts [18, 
21-24, 38]. Novel variants of VlsE are generated throughout vertebrate infections by 
unidirectional recombination of a random segment from one of several unexpressed, 
paralogous vls cassettes into the vlsE expression site [18, 19]. Variations among the 
unexpressed vls cassettes are concentrated in six regions that correspond to the six 
antibody-accessible, surface-loop structures of the VlsE protein [18, 69]. The probability 
of evading detection by antibodies targeting previously expressed VlsE is expected to 
correlate with the sequence variability of VlsE. As the sequence variability of VlsE is 
correlated with the variability among the unexpressed vls cassettes, natural selection 
should favor maximal among-cassette diversity in order to maximize alterations in the 
VlsE sequence [27]. However, only a subset of the sites within the loop structures are 
variable [18, 61]. The absence of variability at the remaining sites in the antigenically-
important loop structures suggests that these sites are either rarely targeted by antibodies 
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or are constrained to be invariant by other selective forces such as maintenance of protein 
structure or function. 
The degree to which an antigen must change to escape binding by an antibody depends 
largely on the physicochemical properties of the amino acids that are recognized by the 
antibody. Antigen-antibody contact regions consist of an average of 18 amino acids in the 
antigen [70], each of which has a quantitatively different effect on antibody-antigen 
reactivity. Variation among amino acids in their effect on binding affinity has been most 
strongly correlated with the solvent accessible surface areas of amino acid residues [71, 
72]. Other physicochemical or statistical properties of amino acid residues including 
hydrophilicity [73, 74] and statistical epitope propensity [75] are also correlated with 
reactivity between residues and antibodies. Thus, the amino acid sites in VlsE that have 
large solvent accessible surface areas, are hydrophilic, and have high epitope propensity 
scores are likely to have the largest effect on immune evasion when mutated, and are thus 
the sites that are expected to be variable among vls cassettes.  
In this study, we investigated the structural and physicochemical properties of amino 
acids in the antigenically-important surface loops of VlsE to assess if variable amino acid 
sites have a larger effect on antibody reactivity. We addressed this hypothesis through 
computational structural analyses of the VlsE antigen and by experimentally testing the 
effect of altering variable or invariant sites on antibody reactivity.  
4.2. Materials and Methods 
4.2.1. Correlations between amino acid variability and metrics of antibody reactivity 
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The published VlsE crystal structure from Bb clone 5A3 ([PDB:1L8W], chain B) [69] 
was used to computationally investigate the hypothesis that amino acid residues that are 
more reactive to antibodies are more likely to be altered during antigenic variation. 
Variable and invariant amino acid sites in the surface exposed loops of VlsE were 
identified as previously described [18, 61]. We used three metrics to assess reactivity to 
antibodies; 1. solvent accessible surface area, 2. hydrophilicity, and 3. statistical epitope 
propensity. Solvent accessible surface areas of each amino acid residue in the six surface 
loops in VlsE were calculated based on the published VlsE crystal structure using the 
POPS algorithms [76]. The hydrophilicity of each amino acid was estimated using the 
Parker hydrophilicity scale [73]. Statistical epitope propensities (the log-odds ratio of the 
frequencies of a type of amino acid appearing in known epitopes) were estimated as 
previously described [75]. The solvent accessibility, hydrophilicity, and epitope 
propensities of invariant VlsE amino acids – those that are never altered by 
recombination with any vls cassette – were compared to the solvent accessibility, 
hydrophilicity, and epitope propensities of variable amino acids.  
4.2.2. Antibody binding sites predicted by computational docking analysis 
Antibody reactivity of amino acid residues in VlsE was also computationally predicted by 
conducting protein-protein docking analyses. 394 antibody light or heavy chains whose 
structures have been solved were extracted from the Protein DataBase as described by 
Kunik et al (structural consensus among antibodies). Automated protein docking was 
performed between VlsE and each of the 394 antibodies light or heavy chains using the 
ClusPro server under Antibody Mode. For each VlsE-antibody pair, the docking model 
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with the highest score was used to identify the antibody-reactive amino acid residues in 
VlsE. In each model, residues in VlsE that have any atoms that are less than 4A away 
from any atoms in the antibody were identified as antibody-reactive. The number of times 
a VlsE residue is identified as antibody-reactive in the 394 VlsE-antibody docking 
models was used to infer the antibody reactivity of the residue. 
4.2.3. Experimental effect of altering amino acid residues on antibody reactivity 
The effect of changing either naturally variable or invariant amino acid sites in the 
surface exposed loops of VlsE on antibody reactivity was investigated using recombinant 
wild-type and mutant VlsE proteins. The DNA sequence of the wild-type vlsE was 
amplified from Bb (clone 5A3) using primers 5A3F 
(CGGGGATCCCAGCCAAGTTGCTGATAAGGACGACCC) and 5A3R 
(CGGAAGCTTCAATCATGAGGGCATAGTCGTGTCCATACA). The ends of the 
amplicon were digested with BamHI and HindIII prior to ligation into expression vector 
pET45(b) (Novagen). The wild-type VlsE protein was expressed in E. coli BL21 (DE3), 
purified using Ni-NTA Superflow Resin (Qiagen), and dialyzed overnight in 100mM 
NaCl, 50mM Tris-8 and 0.1% Tween-20. Polyclonal antibodies against the wild-type 
VlsE protein were generated in two rabbits at Anaspec, Inc. (Fremont, CA).  
VlsE mutant proteins were generated by alanine scanning mutagenesis [77]. A single 
amino acid was changed to an alanine using the Quikchange mutagenesis kit (Agilent 
Technologies) in each of 28 VlsE mutant proteins, 18 of which are found in loop 1 and 10 
in loop 4 (Figure 4-1). Loop 1 and Loop 4 were chosen because approximately half of the 
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amino acid sites are variable in each of the two loops. VlsE mutant proteins were 
expressed and purified as described for the wild-type VlsE protein. 
 
Figure 4-1. The 28 VlsE mutant proteins used in this study. The amino acids replaced by 
alanine in each of the mutant VlsE are shown in red. Sites coding for alanine in the wild-
type protein were not altered. The amino acids that are naturally variable in surface 
exposed Loops 1 and 4 are shaded in the wild-type (WT) amino acid sequences. Mutant 
VlsE proteins are named after the location of the mutation in the wild-type protein. For 
example, the mutation in mutant protein L1M140 is at the 140th amino acid residue which 
falls in loop 1. 
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 ELISA was used to assess the effect of each mutation on antibody reactivity. However, 
background noise associated with cross-reactive antibodies that bind both the wild-type 
and mutant antigens in areas unaffected by the single amino acid substitution hindered 
measurements of the effect of the mutated residue. In this study, background reactivity 
was reduced by negative purification of the antisera (Figure 4-2). Negative purification 
was performed by coating wells of standard ELISA plates with the focal VlsE mutant 
(50μg/mL) diluted in PBS (4°C overnight), blocking with BSA diluent/blocking solution 
(KPL; 4°C overnight), and then incubating rabbit antisera in wells for 90 minutes at room 
temperature. The antibodies generated against the wild-type VlsE that bind to the focal 
mutant, and are thus cross-reactive, were removed by repeating this process six times, 
each time transferring the antisera into a new well coated with the same focal VlsE 
mutant and incubating for 90 minutes (Figure 4-2A). After six rounds of negative 
purification, only antibodies that bind to the wild-type but not to the mutant VlsE are 
expected to remain in the antisera (Figure 4-2B).  
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Figure 4-2. Negative purification of antisera for high-sensitivity ELISA by adsorption 
with a focal VlsE mutant. (A) Cross-reactive antibodies are removed by adsorption to the 
focal mutant antigen. The quantities of remaining antibodies, which are not cross-reactive, 
are measure by ELISA using the wild-type antigen. (B) Negative purification of antisera 
increases sensitivity in immuno-assays. Negative purification consistently reduced the 
background noise in immuno-assays resulting in high precision data. In the figure, 
antisera generated by rabbit II were progressively adsorbed with the wild-type or one of 
two VlsE mutants. “0 Rounds” shows the reactivity of the antisera to the wild-type VlsE 
without prior negative purification. 
 
Post negative-purification antisera were used in a standard indirect ELISA using wild-
type VlsE as the target antigen under standard procedures recommended by abcam, with 
a final wild-type VlsE concentration of 7.5μg/mL used to coat ELISA wells. Goat-anti-
rabbit HRP was used as the secondary antibody and Turbo TMB was used as the 
chromogen. ELISA signals were measured by reading absorbance at 450nm (A450). The 
ELISA signals reflect the amount of antisera that did not bind to the focal VlsE mutant 
used for negative-purification, which correspond to the proportion of antibodies that do 
not bind to the mutant VlsE due to the mutation (Figure 4-2A). That is, the quantity of the 
antibodies remaining after negative-purification shows the effect of the amino acid 
substitution on antibody reactivity (Figure 4-2B). All absorbance readings were 
normalized by the absorbance reading from a control well on each ELISA plate to 
account for among-plate variation. The control well used antisera adsorbed with the wild-
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type VlsE. Thus, mutations that do not affect antibody reactivity result in a normalized 
score (A450(mutant) / A450(wt)) equal to 1. 
 
4.3. Results 
4.3.1. Computationally-determined correlation between antibody reactivity and 
variability of amino acid residues in VlsE 
Amino acid sites that are variable during antigenic variation in all surface loops have 
significantly larger solvent accessible surface areas, which is strongly associated with 
antibody reactivity, than the invariant amino acid sites (Figure 4-3A). Further, surface 
accessibility is greater at variable amino acid sites than at invariant sites that use the same 
amino acid residue (Figure 4-3B). Amino acid sites that are variable during antigenic 
variation also have significantly larger hydrophilicity and epitope propensity scores 
(Figure 4-3C,D), both of which are associated with greater targeting by antibodies. 
Unlike solvent accessible surface area, the hydrophilicity index and epitope propensity 
score are not conditional on the three-dimensional structure of the protein. Consistently, 
antibodies bind to variable amino acid sites significantly more often than the invariant 
amino acid sites, as is demonstrated by the antibody-antigen docking analyses (Figure 4-
3E).   
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Figure 4-3. Metrics of antigenicity are significantly greater at variable amino acid sites 
than at invariant sites. (A) Solvent accessible surface areas of the variable amino acid 
sites are significantly greater than at the invariant sites in all surface loops. (B) Even 
among sites that use the same amino acid, the solvent accessible surface area is greater at 
variable sites than invariant sites. Only the seven types of amino acids that are found in 
both the variable and invariant sites are shown. Hydrophilicity (C) and statistical epitope 
propensity (D) are also significantly greater at variable sites than at the invariant sites in 
all surface loops. (E) Antibody docking analysis also suggests that variable amino acid 
residues have higher reactivity to antibodies. 
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4.3.2. Inconsistent experimental correlation between antibody reactivity and variability 
at amino acid sites in VlsE 
Changes in antibody reactivity caused by experimentally altering variable or invariant 
amino acid residues in two surface exposed loop regions are summarized in Table 4-1. 
Although the amino acids that are altered during antigenic variation have greater solvent 
accessibilities, are more hydrophilic, and have greater epitope propensities than invariant 
sites, experimentally changing amino acids at variable sites to alanine does not result in a 
greater reduction in antibody reactivity than experimentally changing invariant sites 
(Figure 4-4). In fact, several invariant amino acids have large impacts on antibody 
reactivity when mutated (Table 4-1). Among variable sites, there is a statistically 
insignificant positive correlation between the changes in antibody reactivity due to a 
mutation and accessible surface area (Figure 4-5). Changes in antibody reactivity caused 
by each experimentally-introduced mutation were varied considerably among the antisera 
from different rabbits, thus resulting in inconsistent correlations between antibody 
reactivity and solvent accessibility (Figure 4-6).  
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Mutant Solvent accessible surface 
area of the mutated residue 
(A2) 
A450(mutant) / 
A450(wt)  
Rabbit I 
A450(mutant) / 
A450(wt)  
Rabbit II 
L1M140 21.58 1.116±0.066 1.202±0.097 
L1M141 55.93 1.200±0.096 1.222±0.087 
L1M142 19.53 1.390±0.097 1.490±0.059 
L1M143 114.28 1.818±0.094 1.967±0.055 
L1M146 17.91 3.086±0.148 1.380±0.037 
L1M147 22.84 1.929±0.093 2.055±0.046 
L1M148 43.95 1.683±0.205 1.982±0.128 
L1M149 24.52 1.342±0.026 1.513±0.121 
L1M150 24.17 1.800±0.229 1.436±0.086 
L1M152 97.37 1.822±0.128 1.362±0.077 
L1M154 147.16 1.815±0.034 1.427±0.079 
L1M157 105.54 1.066±0.029 1.240±0.073 
L1M158 56.74 1.590±0.064 1.382±0.033 
L1M160 35.15 3.208±0.155 1.502±0.047 
L1M161 125.25 2.801±0.120 1.670±0.094 
L1M163 11.86 1.204±0.025 1.362±0.062 
L1M164 13.54 2.760±0.142 1.340±0.096 
L1M165 62.07 1.476±0.126 1.806±0.180 
L4M243 151.12 1.101±0.116 1.667±0.254 
L4M244 42.81 1.034±0.128 1.559±0.216 
L4M245 77.87 1.104±0.063 1.494±0.185 
L4M246 21.14 1.208±0.042 1.570±0.097 
L4M247 68.7 1.769±0.088 1.344±0.022 
L4M248 43.6 1.315±0.048 1.657±0.153 
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L4M249 13.01 1.692±0.069 1.842±0.161 
L4M250 36.63 1.268±0.052 1.396±0.071 
L4M251 83.14 2.863±0.269 1.502±0.085 
L4M253 76.93 1.373±0.147 1.415±0.079 
 
Table 4-1. Antibody reactivity of mutated amino acid residues in 28 VlsE mutants. 
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Figure 4-4. Changes in antibody reactivity caused by mutating variable or invariant 
amino acid residues. Mutations at variable amino acid sites do not provide a greater 
reduction in antibody reactivity than mutations at invariant sites. The expected decrease 
in antibody binding caused by mutations in variable sites was detectable only in the 
antibodies targeting loop 4 from rabbit I but not antibodies from rabbit II. Mutations in 
the invariant sites of loop 1 had a greater effect on antibody reactivity than mutations to 
variable sites in antibodies from rabbit I but not rabbit II. 
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Figure 4-5. Correlation between antibody reactivity and the solvent accessible surface 
area of variable amino acid residues. Change in antibody reactivity caused by changing a 
single residue at a variable site is weakly and insignificantly correlated with the solvent 
accessible surface area of the amino acid residue. 
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Figure 4-6. Immune reactivity to the same VlsE mutants was inconsistent among antisera 
raised in different rabbits. ELISA results were shown for each VlsE mutant reacting with 
negatively purified antisera generated from rabbit I and rabbit II. 
 
4.3.3. Data reliability after negative purification 
Negative purification successfully reduced background variation in ELISA and the results 
were repeatable. For example, antisera (from rabbit II) adsorbed using the wild-type VlsE 
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or two mutant VlsE variants (L1M160 or L4M253) exhibited decreasing variance in 
ELISA readings with increasing rounds of negative purification (Figure 4-2B). 
Adsorption with wild-type VlsE followed by ELISA using wild-type VlsE as the target 
antigen consistently resulted in the weakest signal, as expected. Adsorption with mutant 
L1M160 followed by ELISA using wild-type VlsE as the target antigen consistently 
resulted in a greater ELISA signal than adsorption with mutant L4M253, regardless of the 
number of rounds of negative purification. Interestingly, antibody reactivity to each VlsE 
mutant differed qualitatively among antisera from different rabbits (Figure 4-6). That is, a 
VlsE mutant that resulted in a large reduction in antibody reactivity in one rabbit may 
have had only a moderate impact on antibody reactivity using the antisera from a 
different rabbit. 
4.4. Discussion 
Antigenic variation systems in pathogens generate divergent antigens in order to evade 
recognition by host antibodies. Natural selection is expected to favor alterations at amino 
acid positions that effectively reduce antibody reactivity [27, 61]. Thus, naturally 
occurring changes in antigens are expected to occur at amino acid positions that are 
commonly and effectively targeted by antibodies [78, 79]. By computationally analyzing 
the structural features of VlsE, we found that amino acid positions that are most likely to 
be variable in a primary surface antigen of Bb, VlsE, are those with properties associated 
with high antibody reactivity including larger accessible surface areas, higher 
hydrophilicity, and higher epitope propensity scores (Figure 4-3). The correlation 
between accessible surface area and the antigenic importance of amino acids is well-
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established and is one of the most important variables used in epitope prediction [71, 72]. 
Indeed, the correlation between variability and antigenicity is further supported by the 
results from antibody docking analysis. However, prediction from accessible surface area 
and antibody docking relies on the accuracy of the crystal structures and is thus subject to 
crystallization artifacts. Hydrophilicity and statistical epitope propensity scores, on the 
other hand, are crystal structures-independent and were also greater at variable sites than 
invariant sites. The agreement among the crystal structure-dependent and independent 
results is consistent with the hypothesis that variable amino acids are more likely to be 
targeted by antibodies than invariant amino acids. 
Nonetheless, the support for the hypothesis that variable amino acids in VlsE have a 
greater effect on antibody reactivity is weak and inconsistent in the experimental data 
(Figure 4-4, 4-5). Despite limited surface exposure and no potential to vary in the face of 
antibody pressure, many invariant amino acids had as great an effect on antibody 
reactivity as did variable sites (Figure 4-4). For example, mutations at two invariable sites 
(L1M146 and L1M160) cause the largest reductions in antibody reactivity in rabbit I 
antisera among all mutants (Table 4-1). One explanation for the discrepancy in the 
computational and experimental results is that the computational results are artifacts. 
However, this explanation is not likely given the consistency among the results from four 
computational matrices. Another possible explanation is that altering naturally invariant 
amino acids, which have less surface exposure and are more hydrophobic, destabilizes 
protein structure [80] resulting in conformational changes that strongly affect antibody 
binding [81]. The effect of altering invariant amino acids on the conformational stability 
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and function of VlsE is likely to be highly detrimental and thus selected against [31], 
despite the potential advantages for antigenic escape. Future investigations into the 
structural and molecular changes caused by mutating variable and invariant sites may 
identify targets of natural selection that have organized the locations and composition of 
residues at sites that are variable among the vls cassettes. 
The weak and inconsistent experimental patterns in antibody reactivity reductions may 
also be caused by the stochasticity in immune development among animals, the limited 
effects of alanine on antibody reactivity, or the limited effect of changing only one amino 
acid on antibody reactivity. Antisera from the different rabbits often had different 
reactivity to the same VlsE mutant (Figure 4-6). For example, one mutation in loop 1 
(L1M160) resulted in the most dramatic decline in antibody reactivity among all 
mutations from rabbit I antisera but only moderate declines in reactivity from rabbit II 
antisera. Variation among individuals in epitope targeting is common (for example see 
[82]), suggesting that antisera from a large number of experimental animals may be 
necessary to deduce general trends. 
The inconsistent empirical patterns may also be attributed to the use of alanine scanning 
mutagenesis. Alanine scanning is a conservative technique used to understand the 
functional effects of individual sites in a protein because alanine is likely to have the least 
effect on protein structure due to limited steric and charge effects [83]. Although 
conservative, alanine scanning mutagenesis did reveal an empirical relationship between 
antibody reactivity and accessible surface area among the variable amino acid sites. This 
pattern was, however, much less clear than the correlation between accessible surface 
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areas and variability demonstrated computationally. Experimentally replacing the focal 
amino acids with residues that are found in naturally occurring VlsE variants may reveal 
a clearer pattern consistent with the hypothesis that natural selection influences both the 
sites that are variable and the types of residues used at those sites [61]. However, 
invariant sites do not have alternative residues in naturally occurring VlsE variants. Thus, 
only conservative techniques such as alanine scanning allow for comparisons of the 
effects of altering variable and invariant sites.  
Investigating changes in antibody reactivity by altering amino acids individually may 
have resulted in empirical patterns that were less consistent than computational 
predictions due to the limited impact of individual amino acids. In natural Bb infections, 
an average of 5 to 89 nucleotides are altered during each recombination event [20], 
suggesting that changing more than one amino acid may be needed to detect 
consequential reductions in antibody reactivity. Further, the combination of altered amino 
acids may have an epistatic effect on antibody reactivity that would not be detected with 
the alanine scanning approach. Although changes in antibody reactivity caused by one 
amino acid substitution may be difficult to detect empirically, removal of the background 
noise by negative purification of antisera enabled precise estimates of changes in 
antibody reactivity. Negative purification is a useful tool to increase sensitivity of ELISA 
and other antibody-based immunoassays that can be coupled with semi-rational 
mutagenesis methods for high-throughput mapping of polyclonal epitopes. 
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Chapter 5. Discussion 
The ability of microbes to maintain high diversity is important for survival within adverse 
and rapidly changing environments [84, 85]. As an example, the vls antigenic variation 
system in the Lyme disease bacteria Borrelia burgdorferi (Bb) continuously generates 
diversity at a site coding for an immunodominant surface antigen, VlsE, facilitating 
evasion from host antibody recognition and is required for establishing long term 
infection [18, 22-24, 38, 39]. The vls antigenic variation system is not only an essential 
component in the pathogenesis of Bb but also a typical molecular mechanism bacteria use 
to cope with rapidly changing environments. Recognizing the clinical and evolutionary 
importance of the system, we studied the forces of natural selection that drive the 
evolution of the vls antigenic variation system in the work presented in Chapter 2, 
Chapter 3 and Chapter 4 of this thesis. Below we discuss the major findings, broad 
significance, applications and limitations of the studies presented in each chapter.  
In Chapter 2 we studied selection for sequence-level diversity among VlsE variants and 
translational optimality of VlsE variants. The recombination events between vlsE and the 
vls unexpressed cassettes were modeled according to experimentally derived data. By 
modeling and simulating antigenic variation, we described the array of VlsE variants that 
can be generated by the natural vls antigenic variation system and compared those to the 
VlsE variants generated from cassettes that were computationally perturbed. This 
computational method can be applied to identify evidence of natural selection in similar 
systems that alter antigenic sequences using recombination-based mechanisms, such as 
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Plasmodium falciparum [86] and Neisseria meningitides [87]. The predictions made by 
the computational method can be empirically tested by competitive, mixed infection of 
vertebrate hosts using the natural strain of Bb and genetically modified Bb strains that 
carry perturbed unexpressed cassettes. 
In this Chapter, we showed that the nucleotide identities at and positions of the variable 
sites within the variable regions of the vls antigenic variation system are organized to 
promote diversity among VlsE variants, consistent with the hypothesis that higher 
diversity should be favorable within an adversely changing environment. In addition, we 
found that translational ability and efficiency of the VlsE variants may constrain the 
selection for higher sequence diversity. Although these findings are statistically 
significant, in terms of effect size, the difference in VlsE sequence diversity and codon 
optimality between natural and perturbed antigenic variation systems is small. Therefore, 
Chapter 2 provides statistical evidence that both diversifying and stabilizing selection has 
acted on the vls antigenic variation system, but the fitness impact of such selections is 
unclear. It is also unclear how selection affects biological traits of Bb, such as the 
dynamics of Bb within vertebrate hosts. 
In Chapter 3, we investigated the biological significance of the diversity among VlsE 
variants. Specifically, we studied how strongly the sequence diversity among VlsE 
variants can affect Bb dynamics within vertebrate hosts. First, we mathematically 
modeled Bb dynamics within vertebrate hosts and then asked if the dynamic models, 
accounting for different microbiological and immunological mechanisms, can replicate 
experimental data. We showed that to reproduce the experimental time series of Bb 
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abundance observed in laboratory mice, the dynamic models need to include mechanisms 
supporting immune evasion or fluctuating immune pressure, in addition to antigenic 
variation in VlsE. We reproduced the experimental data by including two mechanisms – 
antibody immunodominance and fluctuation of immune effector cells – independently 
into the dynamic model. The two mechanisms are well-characterized and commonly 
happen during early stages of bacterial infections [25, 68]. It is important to note that the 
dynamic models are not suitable for making quantitative predictions because, first, the 
two mechanisms are not mutually exclusive; second, the experimental time series may 
also be reproduced under other mechanisms such as dissemination of the bacteria to 
different infection sites. However, the two dynamics models make qualitatively different 
predictions of the Bb dynamics when accounting for the two mechanisms: The model that 
includes antibody immunodominance predicts that the Bb abundance will decrease to a 
stable level following the initial expansion of antibodies, while the model including 
immune effector cells predicts that the Bb abundance will fluctuate continuously. Such 
difference can be tested experimentally to compare the likelihood of the two mechanisms. 
Finally, we used the dynamics model to explain the biological significance of the 
diversifying selection among VlsE variants identified in Chapter 2. We demonstrated that 
a small difference in VlsE diversity can translate into significantly different Bb level 
when immune clearance is efficient, suggesting that a small difference in genetic 
diversity could result in substantial variation in a relevant trait value.   
In Chapter 4, we studied natural selection that acts on structure-level properties of VlsE. 
Specifically, we tested the hypothesis that the variable amino acid residues in VlsE are 
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more likely targeted by antibodies than the invariable residues. Variability of amino acid 
residues in VlsE was positively correlated to four different matrices that predict antibody 
reactivity of the residues, consistently supporting the hypothesis that variable amino acid 
residues in VlsE are more likely targeted by antibodies than the invariable residues. 
However, this hypothesis was not supported by experimental epitope mapping data: 
Mutating a naturally variable residue did not always result in a greater reduction in 
antibody reactivity than mutating a naturally invariable residue. There are several 
mechanisms that could explain such discrepancies. First, the computationally determined 
correlations between variability and antigenicity may be artifacts. Second, the biological 
signal could be obscured by noise from alanine-scanning mutagenesis and diversity 
between the immune systems of the rabbits used to raise the antibodies. Third, the 
discrepancy could be due to purifying selection acting on the invariable residues to 
prevent structural perturbation of the VlsE protein. In particular, the third potential 
mechanism described a set of conflicting selective forces that promote antigenic diversity 
while maintaining the structure of the protein. The hypothesis is biologically intriguing 
and can be tested by analyzing the structural effect of mutating naturally variable or 
invariable amino acid residues in VlsE.  
Consistent with the expectations, our findings suggest that rapidly changing 
environments select for higher diversity at the locus encoding for molecules at the 
interface of the microbe and the environment, such as the variable protein antigen VlsE 
[12, 84, 85]. Each variant of the molecule permits survival within only a subset of the 
temporally variable environmental states. For example, each VlsE variant can evade 
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certain types of antibodies but is effectively targeted by other antibodies. Therefore, 
microbial populations can track and survive multiple environmental states by maintaining 
high diversity at such loci [85, 88]. It is worth noting that diversity can be measured in 
different traits: from genetic diversity (diversity on sequence level) to diversity at 
different levels of organization such as protein structure, antibody reactivity and 
microbial fitness. The thesis demonstrates that, although the traits at these levels of 
organization are derived from the same genetic basis, their patterns of diversity may 
differ. For instance, in Chapter 3 we showed that small sequence diversity among VlsE 
variants can translate into substantially larger difference in Bb abundance; in Chapter 4 
we showed that mutating a single amino acid residue at different positions in different 
VlsE variants, resulting in the same degree of sequence difference between the mutants 
and the wild-type VlsE, can lead to substantially different interactions with the same 
polyclonal antibodies. The different patterns of diversity may result from the fact that 
traits are connected nonlinearly by biological processes such as gene expression, protein 
folding and localization, antibody-antigen interaction and immune selection. Moreover, 
diversity in different traits is likely constrained by various types of stabilizing or 
purifying selections. For instance, this thesis suggests that the diversity of VlsE variants 
at the DNA-sequence level is likely constrained by translational efficiency of the VlsE 
variants, and that diversity at protein structure level might be constrained by natural 
selection for the structural stability of the protein.  
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